Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo

P. Mobasher, R. Guerra, S. J. Li, J. Frangos, A. K. Ganesan, V. Huang

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
JournalBritish Journal of Dermatology
DOIs
StateAccepted/In press - Jan 1 2019

ASJC Scopus subject areas

  • Dermatology

Cite this